Mats Wahlstrom Coherus Bio Sciences, Inc. (CHRS) insider trading activity

CHRS Quotes by TradingView

Mats Wahlstrom is of Coherus BioSciences, Inc.. Currently has a direct ownership of 0 shares of CHRS, which is worth approximately $0. The most recent transaction as insider was on Feb 09, 2024, when has been sold 99,988 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Mats Wahlstrom Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2024
SELL
Bona fide gift
-
99,988 Reduced 100.0%
0 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
$100,179 $1.67 p/Share
59,988 Added 37.5%
99,988 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$62,388 $2.08 p/Share
29,994 Added 42.85%
40,000 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
$116,470 $11.64 p/Share
10,006 Added 50.0%
10,006 Common Stock

Also insider at

MTACW
MedTech Acquisition Corp
Director
MW

Mats Wahlstrom

Redwood City, CA

Track Institutional and Insider Activities on CHRS

Follow Coherus BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

News

Receive news related to Coherus BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CHRS